In our study, we investigated the relationship between PD-1 and PD-L1 molecules and drug resistance in the context of chemotherapy- and immunotherapy-focused treatments, using an in vitro breast cancer model developed with monocyte and lymphocyte cells to explore the immune basis of breast cancer. The gene discussed is CD274; the disease is breast carcinoma.